1. Home
  2. NABL vs SGP Comparison

NABL vs SGP Comparison

Compare NABL & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$3.71

Market Cap

945.6M

Sector

Technology

ML Signal

HOLD

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$19.17

Market Cap

932.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NABL
SGP
Founded
2000
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
945.6M
932.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NABL
SGP
Price
$3.71
$19.17
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$8.31
$45.00
AVG Volume (30 Days)
1.5M
50.1K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$511,430,000.00
N/A
Revenue This Year
$11.04
N/A
Revenue Next Year
$8.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.71
N/A
52 Week Low
$3.24
$19.46
52 Week High
$9.04
$30.56

Technical Indicators

Market Signals
Indicator
NABL
SGP
Relative Strength Index (RSI) 39.48 29.82
Support Level $3.24 N/A
Resistance Level $5.11 $26.29
Average True Range (ATR) 0.31 1.59
MACD -0.01 -0.38
Stochastic Oscillator 30.39 2.61

Price Performance

Historical Comparison
NABL
SGP

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: